A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
How to present treatment effects of implantable defibrillators? Statistics, baseline risk, and meaningful benefit
Patients with left ventricular dysfunction are prone to sudden cardiac death, presumably from ventricular tachyarrhythmias. Randomized controlled trials (RCTs) demonstrated that prophylactic implantable cardioverter-defibrillators (ICDs) improve survival among selected patients with left ventricular dysfunction considered at high risk of sudden cardiac death. Based on these clinical trial data, the indications for ICD therapy rapidly expanded from restricted therapy of 'last resort' (secondarydoi:10.1093/europace/eut064 pmid:23515339 fatcat:nfcvma56t5gzvldagh4pyqzxr4